OFI Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$6.18M Sell
44,159
-765
-2% -$115K 0.4% 41
2015
Q2
$7.37M Buy
44,924
+3,254
+8% +$520K 0.43% 33
2015
Q1
$6.43M Sell
41,670
-5,947
-12% -$847K 0.38% 46
2014
Q4
$5.98M Buy
47,617
+723
+2% +$89.3K 0.38% 42
2014
Q3
$5.61M Sell
46,894
-3,702
-7% -$425K 0.4% 42
2014
Q2
$5.45M Sell
50,596
-1,709
-3% -$176K 0.39% 42
2014
Q1
$5.21M Sell
52,305
-772
-1% -$69.8K 0.4% 39
2013
Q4
$4.9M Buy
53,077
+2,837
+6% +$252K 0.4% 40
2013
Q3
$4.2M Buy
50,240
+701
+1% +$60.1K 0.4% 41
2013
Q2
$4.05M Buy
+49,539
New +$3.71M 0.42% 39

Other funds holding ELV

OFI Advisors's ELV Position: Q3 2015 in Review

OFI Advisors reduced its Elevance Health (ELV) stake by 1.7% in Q3 2015, selling an estimated $115K and leaving 44,159 shares worth $6.18M. The position accounts for 0.4% of the portfolio, ranked #41.

OFI Advisors first reported a position in ELV in Q2 2013 and has held it in 10 quarters since. The position peaked at $7.37M in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

  • OFI Advisors held 44,159 shares of Elevance Health worth $6.18M as of Q3 2015.
  • OFI Advisors sold 765 Elevance Health shares in Q3 2015, an estimated $115K.
  • Elevance Health made up 0.4% of OFI Advisors's portfolio in Q3 2015, its #41 holding.
  • OFI Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Elevance Health position peaked at $7.37M in Q2 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.